SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Middle East shipping and energy-infrastructure attack concerns are driving crude higher and drawing attention to USO, which tracks WTI futures. Traders are split between bullish supply-disruption fears and bearish calls for a pullback if tensions ease, with some warning the rally is stretched.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is centered on concerns that its debt-heavy AI infrastructure buildout could become harder to finance if borrowing costs stay high or AI demand slows, amplified by bearish HSBC commentary and pressure across neocloud stocks. Traders are split between warnings of further downside and default risk, and bullish arguments that the companys backlog and AI demand support a rebound.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

A steep selloff in USAR and the broader rare-earth sector is driving discussion, with traders pointing to dilution concerns, heavy spending before large-scale production and weak sentiment around management. Some blame short selling or broader market pressure, while bulls argue the companys government backing and domestic magnet ambitions support its long-term case and see the decline as oversold.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO decline is drawing attention, with traders focused on successive share-lockup expirations and reported insider selling as potential sources of supply, alongside a price-target cut and weakness in AI stocks. Bears see continued pressure from valuation and execution concerns, while bulls argue the selloff is overdone and point to the companys AI-chip technology and long-term potential.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

UBSs downgrade of NuScale to Sell, citing long commercialization timelines and a lack of firm customer commitments, is driving the selloff. Traders debate whether it signals deeper execution risks, including delays around the TVA opportunity, or overstates the concerns amid weakness across nuclear stocks; some view the decline as a buying opportunity.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicors Q3 results are driving discussion, with traders emphasizing strong revenue growth and improved margins while debating the GAAP EPS shortfall and the lack of forward guidance. Some view the AI power-delivery and licensing growth as encouraging, while others are cautious about valuation and whether the earnings news is enough to support the stock.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new multiyear buyback are drawing attention, but shares are falling as traders question why the stock dropped despite the results. The debate centers on the unchanged profit-outlook midpoint and weaker vehicle sales versus the buyback and stronger cash-flow outlook.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp pullback across AI and neocloud stocks has focused attention on fears that infrastructure spending may not deliver returns and that tighter financing could pressure providers, with CoreWeaves debt concerns often cited as a sector risk. Traders are divided between buying Nebiuss rebound as an oversold dip and expecting more downside until funding and market conditions improve.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops warrant-expiration notice is driving discussion, as traders debate whether the approaching deadline and possible dilution are weighing on shares or whether unexercised warrants would remove dilution risk. Sentiment is split between frustration with Ryan Cohen and speculation about an extension or other corporate action; those hopes remain unconfirmed.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led rebound in the Nasdaq-100 after a sharp AI-stock selloff, ahead of major technology earnings, has put QQQ in focus. Traders are split over whether the bounce can hold or is a temporary relief rally, citing concerns about AI financing, narrow market breadth and rising oil-related inflation risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is JAZZ Stock Still a Smart Way to Play Medical Cannabis?

Jazz Pharmaceuticals offers a differentiated medical cannabis play, with Epidiolex sales growth and a diversified portfolio offset by pipeline setbacks and earnings pressures.

TSNDF Stock Rises 6.5% in a Month: Time to Buy, Hold or Sell?

TerrAscend's improving revenues, margins and cash flow support its recovery, while debt, competition and regulatory uncertainty remain key concerns.

Wall Street Analysts See a 103.26% Upside in Green Thumb Industries Inc. (GTBIF): Can the Stock Really Move This High?

The consensus price target hints at a 103.3% upside potential for Green Thumb Industries Inc. (GTBIF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Cannabis Stock VRNO Rises 10% in a Month: Time to Buy, Hold or Sell?

Verano's rally follows strong Q2 results, but margin pressure and wider 2026 losses keep the stock in wait-and-watch mode.

Can Green Thumb Industries Inc. (GTBIF) Run Higher on Rising Earnings Estimates?

Green Thumb Industries Inc. (GTBIF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Wall Street Analysts Think Green Thumb Industries Inc. (GTBIF) Could Surge 104.86%: Read This Before Placing a Bet

The mean of analysts' price targets for Green Thumb Industries Inc. (GTBIF) points to a 104.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Should You Buy, Hold or Sell GTBIF Stock Post Q2 Earnings Release?

Green Thumb tops Q2 earnings and sales estimates, but can regulatory catalysts, buybacks and expansion plans outweigh pricing pressure and fierce competition?

Should You Buy, Hold or Sell SNDL Stock Post Q4 Earnings Release?

SNDL sinks after weak Q2 2026 earnings, but can cost cuts and U.S. expansion through Parallel offset ongoing cannabis and liquor headwinds?

Is JAZZ Still the Best Cannabis Stock After Federal Rescheduling?

Jazz Pharmaceuticals pairs its FDA-approved CBD blockbuster with a diversified drug portfolio, offering medical cannabis exposure despite ongoing pipeline risks.

GTBIF Stock Climbs 17.5% in Three Months: Time to Invest or Cash Out?

Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Trulieve, MSOS' largest holding, is set to uplist to the NYSE on Wednesday after restructuring its business around medical cannabis operations.</li><li>The upcoming DEA hearing comes after April's Schedule III move for state-licensed medical marijuana, which removed key tax penalties.</li><li>AdvisorShares said that the rescheduling could boost earnings, cash flow, capital access, banking services and institutional participation across the sector.</li></ul><p>Shares of the AdvisorShares Pure US Cannabis ETF (MSOS) have hit their highest levels in 2026 as investors pile into cannabis stocks ahead of a regulatory hearing due later this month, with Trulieve's landmark NYSE listing adding fuel to the search for the sector's next big winner.</p><p>As of May 31,&nbsp;<a href="https://stocktwits.com/symbol/MSOS">MSOS</a> delivered a 103.7% one-year net asset value (NAV) return, outperforming the North American Marijuana Index's 36.9% gain and the S&amp;P 500's 29.8% return. The ETF has also gained 28% over the past three months, while the marijuana benchmark declined about 1%. As of June 5, MSOS managed $1.13 billion in assets.</p><p><img src="https://news.stocktwits-cdn.com/koyfin_20260609_091032612_png_534f3bee09.webp" alt="koyfin_20260609_091032612.png"></p><h2 class="st-heading-2"><strong>Trulieve Opens NYSE Door</strong></h2><p>Trulieve Cannabis, MSOS' largest holding at 30% of assets, said its shares would begin trading on the NYSE under the symbol TRLV from Wednesday. CEO Kim Rivers called the listing a "historic milestone" and said that the Trump administration's decision to reclassify medical marijuana to Schedule III helped pave the way for the approval.</p><div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col><col><col></colgroup><tbody><tr><td>Company</td><td>Weight</td><td>Price</td><td>PT</td><td>Upside</td></tr><tr><td>Trulieve (TCNNF)</td><td>30.2%</td><td>13</td><td>$16.45</td><td>27%</td></tr><tr><td>Curaleaf (CURLD)</td><td>26.3%</td><td>11.22</td><td>$12.71</td><td>13%</td></tr><tr><td>Green Thumb (GTBIF)</td><td>18.2%</td><td>8.74</td><td>$14.84</td><td>70%</td></tr><tr><td>Glass House (GLASF)</td><td>8.3%</td><td>$13.14</td><td>$10.25</td><td>-22%</td></tr><tr><td>Verano (VRNO)</td><td>5%</td><td>$1.21</td><td>$3.57</td><td>195%</td></tr><tr><td>Cresco (CRLBF)</td><td>4.4%</td><td>$0.95</td><td>$1.89</td><td>99%</td></tr><tr><td>TerrAscend (TSNDF)</td><td>4.2%</td><td>$0.77</td><td>$1.28</td><td>66%</td></tr><tr><td>Jushi (JUSHF)</td><td>1.6%</td><td>$0.53</td><td>$1.0</td><td>183%</td></tr></tbody></table></figure></div><p>The company recently separated its medical cannabis operations from adult-use businesses, allowing it to qualify for a senior U.S. exchange listing. Alliance Global, which maintains a 'Buy' rating and a C$27 price target on Trulieve, said the company is in a "unique" position given its concentration in medical-only states and its exposure to expanding medical markets such as Texas and Georgia.</p><h2 class="st-heading-2"><strong>Why The DEA Hearing Matters</strong></h2><p>The June 29 administrative hearing will examine whether broader marijuana products, including adult-use cannabis, should be moved to Schedule III. The proceeding is expected to run through no later than July 15.</p><p>Investor excitement has been building since April, when Acting Attorney General Todd Blanche moved state-licensed medical marijuana products into Schedule III and launched the process for broader rescheduling. The move eliminated tax penalties for licensed medical cannabis operators, allowing companies to deduct ordinary business expenses such as payroll, rent and interest. Adding to the bullish sentiment, U.S. President Donald Trump on Monday formally nominated Blanche to serve as attorney general permanently.</p><h2 class="st-heading-2"><strong>Cannabis Firms Eye Uplisting Opportunities</strong></h2><p>AdvisorShares said the change could boost earnings, free cash flow, and balance-sheet strength across the industry, while also improving access to capital, banking services, and institutional investors. Roth Capital called the rescheduling order "extremely favorable" for the cannabis sector, citing benefits for taxation, capital access, future uplistings and overall sector investability.&nbsp;</p><p>One of the benefits investors expected from Schedule III came on Monday when Cresco Labs secured a $50 million revolving credit facility from Needham Bank. CEO Charlie Bachtell said the financing provides a "powerful, non-dilutive tool" to fund acquisitions, while positioning the company for access to U.S. capital markets and a future uplisting to a senior exchange.&nbsp;</p><p>While not part of MSOS, Tilray Brands (TLRY) has also positioned itself for potential cannabis reform, saying it may use proceeds from its at-the-market program last month to pursue acquisitions and expansion.</p><h2 class="st-heading-2"><strong>Which MSOS Holding Offers The Biggest Upside?</strong></h2><p>While Trulieve has become the poster child for the industry's regulatory progress, several other MSOS holdings carry higher upside. Verano (VRNO) offers the highest upside at 195%, followed by Jushi Holdings (JUSHF) at 183% and Cresco Labs (CRLBF) at nearly 99%, according to Koyfin data.&nbsp;</p><p>Among MSOS' largest holdings, Green Thumb Industries (GTBIF), a U.S.- based retail company, stands out with a 70% upside, well above Trulieve Cannabis (TCNNF), the ETF's largest position, and Curaleaf Holdings (CURLF), the world's largest cannabis company by revenue.&nbsp;</p><h2 class="st-heading-2"><strong>How Do Retail Traders Feel About Cannabis Stocks?</strong></h2><p>On Stocktwits, sentiment for MSOS, TCNNF and GTBIF was 'extremely bullish' amid 'extremely high' message volume, while TLRY was 'extremely bullish' and CRLBF 'bullish', both on 'high' message volumes.&nbsp;</p><figure class="image"><img src="https://news.stocktwits-cdn.com/msos_ss_png_04cd84375d.webp" alt="msos ss.png" width="970" height="130"><figcaption>MSOS sentiment and message volume as of June 9 | Source: Stocktwits</figcaption></figure><p>One user&nbsp;<a href="https://stocktwits.com/thepalace2007/message/655819130">said</a>, “$MSOS buy the underlyings these 3 will uplist soon $GTBIF $TCNNF $CURLD.”</p><p><stembedurl>https://stocktwits.com/thepalace2007/message/655819130</stembedurl></p><p>Another user&nbsp;<a href="https://stocktwits.com/FreyBentos/message/655820037">said</a>, “$GTBIF and $TCNNF are the best two plays in the cannabis sector and the only two you need to own.”</p><p><stembedurl>https://stocktwits.com/FreyBentos/message/655820037</stembedurl></p><p>MSOS ETF has jumped 143% over the past year.&nbsp;</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oscr-stock-5-year-high-healthy-tailwinds-2026/cZ0xDLpR7be">OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance&nbsp;</a></p>

MSOS ETF has jumped 143% over the past year. (Photo credit: Getty Images)

The cannabis ETF has surged 104% over the past year, outperforming both the North American Marijuana Index and the S&P 500.

Cresco Labs Inc

Green Thumb Industries

AdvisorShares Pure US Cannabis ETF

Tilray Brands Inc

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$6.13
Prev Close	$6.11
Open	$6.11
Dividend Yield	0.00%
50-Day Moving Average	$7.23
Beta	0.74
Avg. Volume	630,258.05
PE Ratio	11.29

52-Week High	$10.43
52-Week Low	$5.29
Market Capitalization	$1.34B
EPS (Annual)	$0.4819
Price to Book	0.72
Revenue Per Employee	$235,059.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

GTBIF Fundamentals